Does lisinopril improve systemic extracellular degradation of collagen type I in patients with essential hypertension?
Lisinopril normalizes depressed systemic extracellular degradation of collagen type I in patients with essential hypertension, which may help prevent organ fibrosis and left ventricular hypertrophy.
These findings suggest that systemic extracellular degradation of collagen type I is depressed in patients with essential hypertension and can be normalized by treatment with lisinopril. A depressed degradation of collagen type I may facilitate organ fibrosis in hypertensive patients, namely, in those with left ventricular hypertrophy.
Laviades et al. (Tue,) studied this question.